A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...

Prostate cancer survivors Mark V. Williamson and Jim East will celebrate with other men who beat the disease, Nov. 16 at the ...

Prostate cancer screening should be backed by ministers regardless of the advice from officials, Rishi Sunak has said.

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A week after an announcement made by Biden's office about former US President's undergoing medical care, Joe Biden rang a ...

Fresh from a European cancer conference that was all about antibody-drug conjugates (ADCs), GSK has turned to French biotech ...

NICE recommends Bayer’s Nubeqa® (darolutamide) plus androgen deprivation therapy as a treatment option for patients with hormone-sensitive metastatic prostate cancer Nubeqa® (darolutamide) plus ...

The National Institute for Health and Care Excellence (NICE) has recommended darolutamide in combination with androgen ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...